Record Details

Patent Policies and Provisions Relating to Pharmaceuticals in India

Online Publishing @ NISCAIR

View Archive Info
 
 
Field Value
 
Authentication Code dc
 
Title Statement Patent Policies and Provisions Relating to Pharmaceuticals in India
 
Added Entry - Uncontrolled Name Nair, Gopakumar G; Gopakumar Nair Associates
Fernandes, Andreya
 
Uncontrolled Index Term Working of patents; patent law; compulsory licence; government use; inventions not patentable; Section 3(d); medicine patent pool
 
Summary, etc. Indian generic pharma industry has established a ‘pride of place’ as the largest generic manufacturer and supplier of essential and life-saving medicines to UNICEF, WHO, MSF and others. India has the largest number of manufacturing facilities approved by the USFDA and EDRM, etc. While the Patents Act and related IP laws are substantially TRIPS compliant and is reasonably well enforced, there is a need for substantial refinement in other pharma related laws such as Drugs and Cosmetics Act, Biodiversity Act. Need for more uniform and stringent enforcement of quality including upgradation of regulatory agencies is also called for. The Indian Patent Law which provides equitable balance between rights and obligation has also been hailed by all the third world countries and acknowledged, though reluctantly, by developed countries. Such a balanced patent law is essential to provide affordable access to essential medicines to the masses. An analysis of the policies and provisions of (Indian) Patents Act, 1970 and other pharma related laws are provided in this article.
 
Publication, Distribution, Etc. Journal of Intellectual Property Rights (JIPR)
2023-04-03 15:56:55
 
Electronic Location and Access application/pdf
http://op.niscair.res.in/index.php/JIPR/article/view/2963
 
Data Source Entry Journal of Intellectual Property Rights (JIPR); ##issue.vol## 19, ##issue.no## 1 (2014): Journal of Intellectual Property Rights
 
Language Note en